The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Dorothy K. Hatsukami

Department of Psychiatry

University of Minnesota Tobacco Research Programs

717 Delaware St SE

Room 260

USA

[email]@umn.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Psychiatry, University of Minnesota Tobacco Research Programs, 717 Delaware St SE, Room 260, USA. 2004 - 2012
  • Tobacco Use Research Center, University of Minnesota, 717 Delaware St SE, Minneapolis, USA. 2003 - 2010
  • University of Minnesota Transdisciplinary Tobacco Use Research Center, Minneapolis, MN 55414, USA. 2005 - 2010

References

  1. Tobacco and nicotine product testing. Hatsukami, D.K., Biener, L., Leischow, S.J., Zeller, M.R. Nicotine Tob. Res. (2012) [Pubmed]
  2. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Hatsukami, D.K., Jorenby, D.E., Gonzales, D., Rigotti, N.A., Glover, E.D., Oncken, C.A., Tashkin, D.P., Reus, V.I., Akhavain, R.C., Fahim, R.E., Kessler, P.D., Niknian, M., Kalnik, M.W., Rennard, S.I. Clin. Pharmacol. Ther. (2011) [Pubmed]
  3. Nicotine reduction revisited: science and future directions. Hatsukami, D.K., Perkins, K.A., Lesage, M.G., Ashley, D.L., Henningfield, J.E., Benowitz, N.L., Backinger, C.L., Zeller, M. Tob. Control (2010) [Pubmed]
  4. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Hatsukami, D.K., Kotlyar, M., Hertsgaard, L.A., Zhang, Y., Carmella, S.G., Jensen, J.A., Allen, S.S., Shields, P.G., Murphy, S.E., Stepanov, I., Hecht, S.S. Addiction (2010) [Pubmed]
  5. Commentary on Post et al. (2010): Snus, a cautionary reminder. Hatsukami, D.K., Tomar, S. Addiction (2010) [Pubmed]
  6. Clinical trials methods for evaluation of potential reduced exposure products. Hatsukami, D.K., Hanson, K., Briggs, A., Parascandola, M., Genkinger, J.M., O'Connor, R., Shields, P.G. Cancer Epidemiol. Biomarkers Prev. (2009) [Pubmed]
  7. Tobacco addiction. Hatsukami, D.K., Stead, L.F., Gupta, P.C. Lancet (2008) [Pubmed]
  8. Nicotine addiction: past, present and future. Marian Fischman lecture given at the 2007 meeting of CPDD. Hatsukami, D.K. Drug. Alcohol. Depend (2008) [Pubmed]
  9. Smokeless tobacco reduction: preliminary study of tobacco-free snuff versus no snuff. Hatsukami, D.K., Ebbert, J.O., Edmonds, A., Li, C., Lin, H., Le, C., Hecht, S.S. Nicotine Tob. Res. (2008) [Pubmed]
  10. Effects of high dose transdermal nicotine replacement in cigarette smokers. Hatsukami, D., Mooney, M., Murphy, S., LeSage, M., Babb, D., Hecht, S. Pharmacol. Biochem. Behav. (2007) [Pubmed]
  11. Smokeless tobacco brand switching: a means to reduce toxicant exposure? Hatsukami, D.K., Ebbert, J.O., Anderson, A., Lin, H., Le, C., Hecht, S.S. Drug. Alcohol. Depend (2007) [Pubmed]
  12. Changing smokeless tobacco products new tobacco-delivery systems. Hatsukami, D.K., Ebbert, J.O., Feuer, R.M., Stepanov, I., Hecht, S.S. Am. J. Prev. Med (2007) [Pubmed]
  13. Developing the science base for reducing tobacco harm. Hatsukami, D.K., Joseph, A.M., Lesage, M., Jensen, J., Murphy, S.E., Pentel, P.R., Kotlyar, M., Borgida, E., Le, C., Hecht, S.S. Nicotine Tob. Res. (2007) [Pubmed]
  14. Biomarkers to assess the utility of potential reduced exposure tobacco products. Hatsukami, D.K., Benowitz, N.L., Rennard, S.I., Oncken, C., Hecht, S.S. Nicotine Tob. Res. (2006) [Pubmed]
  15. Biomarkers to assess the utility of potential reduced exposure tobacco products. Hatsukami, D.K., Benowitz, N.L., Rennard, S.I., Oncken, C., Hecht, S.S. Nicotine Tob. Res. (2006) [Pubmed]
  16. Toxicant exposure in cigarette reducers versus light smokers. Hatsukami, D.K., Le, C.T., Zhang, Y., Joseph, A.M., Mooney, M.E., Carmella, S.G., Hecht, S.S. Cancer Epidemiol. Biomarkers Prev. (2006) [Pubmed]
  17. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Hatsukami, D.K., Kotlyar, M., Allen, S., Jensen, J., Li, S., Le, C., Murphy, S. Chest (2005) [Pubmed]
  18. Methods to assess potential reduced exposure products. Hatsukami, D.K., Giovino, G.A., Eissenberg, T., Clark, P.I., Lawrence, D., Leischow, S. Nicotine Tob. Res. (2005) [Pubmed]
  19. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Hatsukami, D.K., Rennard, S., Jorenby, D., Fiore, M., Koopmeiners, J., de Vos, A., Horwith, G., Pentel, P.R. Clin. Pharmacol. Ther. (2005) [Pubmed]
  20. Characteristics of cigarette smokers seeking treatment for cessation versus reduction. Lemmonds, C.A., Mooney, M., Reich, B., Hatsukami, D. Addict. Behav (2004) [Pubmed]
  21. Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Hatsukami, D.K., Rennard, S., Patel, M.K., Kotlyar, M., Malcolm, R., Nides, M.A., Dozier, G., Bars, M.P., Jamerson, B.D. Am. J. Med. (2004) [Pubmed]
  22. Smokeless tobacco use: harm reduction or induction approach?. Hatsukami, D.K., Lemmonds, C., Tomar, S.L. Prev. Med (2004) [Pubmed]
  23. Harm reduction approaches to reducing tobacco-related mortality. Hatsukami, D.K., Henningfield, J.E., Kotlyar, M. Annu. Rev. Public. Health (2004) [Pubmed]
  24. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Hatsukami, D.K., Lemmonds, C., Zhang, Y., Murphy, S.E., Le, C., Carmella, S.G., Hecht, S.S. J. Natl. Cancer Inst. (2004) [Pubmed]
  25. Preliminary study on reducing oral moist snuff use. Hatsukami, D.K., Edmonds, A., Schulte, S., Jensen, J., Le, C.T., Losey, L., Carmella, S.G., Hecht, S.S. Drug. Alcohol. Depend (2003) [Pubmed]
  26. Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine. Hatsukami, D.K., Jensen, J., Brauer, L.H., Mooney, M., Schulte, S., Sofuoglu, M., Pentel, P.R. Pharmacol. Biochem. Behav. (2003) [Pubmed]
 
WikiGenes - Universities